Filings & corporate actions
1 results filed
CSVDividend
₹656.00 per share · last 24 Jul 2026
2026
- 24 JuldividendDividend · ₹656.00 per share-2.4%
Reaction to results · all yearsrose on day 0 in 1 of 1 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q4 FY10 | 9 Jun 2010 | +1.6% | -0.6% | +7.2% | 0.7× |
| Average | +1.6% | -0.6% | +7.2% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth
CSVRevenue YoY—
Profit YoY—
Interest cost YoY—
Revenue QoQ—
Profit QoQ—
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Profit | — | — | — | — | — | — |
Key data
CSVOpen26,240.00
Day range25,955.00 – 26,550.00
52-week range25,135.00 – 30,655.00
From 52w high-14.8%
RSI (14)43.7
ATR (14)614.70
Volume12.5K
Avg volume (20D)9.0K
Rel volume1.40×
Volatility (1Y)20.3%
Turnover₹32.7Cr
SMA 50 / 20026,775.90 / 26,873.35
Delivery percentage
Latest · 6 Oct 202666.5%
20-day avg52.4%
1-year avg57.4%
Percentile (own history)90th
Range9.9–92.2%
Sessions1,731
Over the last 20 sessions ABBOTINDIA settled 52.4% of its traded quantity, which is above average for an NSE equity. Its one-year average is 57.4%, so recent sessions are running 5.0 points lower than usual. The latest session ranks higher than 90% of the 1,731 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
IndustryPharmaceuticals
Performance returns
CSV| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | -0.48% | -2.34% | +0.66% | -2.28% | -0.65% | -12.19% |
Valuation
CSVMarket cap₹55,493 Cr
P/E (TTM)—
EPS (TTM)—
Shares outstanding—
Listed8 Jan 2010
Ownership
Promoter—
Promoter Δ QoQ—
Public—
FII—
DII—
Pledged—
ABBOTINDIA at a glance
- ABBOTINDIA closed at ₹26,115 on 6 Oct 2026, -0.48% on the day, -12.2% over one year, 14.8% below its 52-week high of ₹30,655.
- Delivery was 66.5% of traded quantity on 6 Oct 2026, the 90th percentile of its own 1,731 sessions with a reading (20-session average 52.4%, 1-year average 57.4%).
- Market capitalisation is ₹55,493 crore, with no positive trailing earnings for a P/E.
About
CSVMacro sectorHealthcare
Basic industryPharmaceuticals
ISININE358A01014
SeriesEQ
Listed8 Jan 2010
History from8 Jan 2010
Sessions4,150
Turnover rank#712
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.
More in Pharmaceuticals & Biotechnology
CSV- DIVISLABDivi's Laboratories Limited9,550.00+3.85%
- LAURUSLABSLaurus Labs Limited2,050.00+3.99%
- SUNPHARMASun Pharmaceutical Industries Limited1,804.10+1.37%
- WOCKPHARMAWockhardt Limited2,176.40+5.47%
- DRREDDYDr. Reddy's Laboratories Limited1,208.00+0.42%
- MOREPENLABMorepen Laboratories Limited143.96+6.41%
- ZYDUSLIFEZydus Lifesciences Limited1,159.50+1.80%
- SYMBIOTECSYMBIOTEC1,149.50-1.73%
- TORNTPHARMTorrent Pharmaceuticals Limited4,772.000.00%
- GLANDGland Pharma Limited3,006.10+3.25%
- LUPINLupin Limited2,029.30+0.91%
- AUROPHARMAAurobindo Pharma Limited1,692.80+1.07%
All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE